首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >ARGONAUT-I: Activity of Cefiderocol (S-649266) a Siderophore Cephalosporin against Gram-Negative Bacteria Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases

【2h】

ARGONAUT-I: Activity of Cefiderocol (S-649266) a Siderophore Cephalosporin against Gram-Negative Bacteria Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases

机译：ARGONAUT-I：头孢呋咯酯（S-649266）（一种铁载体头孢菌素）对革兰氏阴性细菌的活性包括耐碳青霉烯类的非发酵菌和肠杆菌科（具有明确的广谱β-内酰胺酶和碳青霉烯酶）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Antimicrobial Agents and Chemotherapy
作者
Michael R. Jacobs; Ayman M. Abdelhamed; Caryn E. Good; Daniel D. Rhoads; Kristine M. Hujer; Andrea M. Hujer; T. Nicholas Domitrovic; Susan D. Rudin; Sandra S. Richter; David van Duin; Barry N. Kreiswirth; Chris Greco; Derrick E. Fouts; Robert A. Bonomo;
展开▼
作者单位

展开▼
年(卷),期 2019(63),1
年度 2019
页码 e01801-18
总页数 9
原文格式 PDF
正文语种
中图分类药学;微生物学;
关键词

相似文献

外文文献
中文文献
专利

1. ARGONAUT-I: Activity of Cefiderocol (S-649266), a Siderophore Cephalosporin, against Gram-Negative Bacteria, Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum beta-Lactamases and Carbapenemases [J] . Jacobs Michael R., Abdelhamed Ayman M., Good Caryn E., Antimicrobial agents and chemotherapy. . 2019,第1期

机译：Argonaut-I：Cefiderocol（S-649266）的活性，抗革兰阴孢子素，抗革兰阴孢子素，包括耐鲤鱼抗性的诸如肠杆菌的β-内酰胺酶和碳基氨酸酶和肠杆菌酶
2. Cefiderocol (S-649266), A new siderophore cephalosporin exhibiting potent activities against Pseudomonas aeruginosa and other gram-negative pathogens including multi-drug resistant bacteria: Structure activity relationship [J] . Toshiaki Aoki, Hidenori Yoshizawa, Kenji Yamawaki, European Journal of Medicinal Chemistry: Chimie Therapeutique . 2018,第期

机译：Cefiderocol（S-649266），一种新的剑隆头孢菌素，其表现出对铜绿假单胞菌和其他革兰阴性病原体的有效活性，包括多药物抗菌细菌：结构活动关系
3. In Vitro Antimicrobial Activity of a Siderophore Cephalosporin, S-649266, against Enterobacteriaceae Clinical Isolates, Including Carbapenem-Resistant Strains [J] . Kohira Naoki, West Joshua, Ito Akinobu, Antimicrobial agents and chemotherapy. . 2016,第2期

机译：铁载体头孢菌素S-649266对肠杆菌科临床分离株（包括耐碳青霉烯的菌株）的体外抗菌活性。
4. 1351. In vitro Activity of Cefiderocol (S-649266) a Siderophore Cephalosporin Against Enterobacteriaceae With Defined Extended-Spectrum Β-Lactamases and Carbapenemases [O] . Michael R Jacobs, Ayman M Abdelhamed, Caryn E Good, -1

机译：1351.头孢洛考（S-649266）一种铁载体头孢菌素对肠杆菌科细菌具有确定的广谱β-内酰胺酶和碳青霉烯酶的体外活性
5. Activity of cefiderocol (S-649266) against carbapenem-resistant Gram-negative bacteria collected from inpatients in Greek hospitals [O] . Matthew E. Falagas, Tilemachos Skalidis, Konstantinos Z. Vardakas, 2017

机译：Cefiderocol（S-649266）对希腊医院住院患者收集的Cefiderocol（S-649266）的活性

ARGONAUT-I: Activity of Cefiderocol (S-649266) a Siderophore Cephalosporin against Gram-Negative Bacteria Including Carbapenem-Resistant Nonfermenters and Enterobacteriaceae with Defined Extended-Spectrum β-Lactamases and Carbapenemases

著录项

相似文献

相关主题

期刊订阅